BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8413883)

  • 1. Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.
    Baltuch GH; Couldwell WT; Villemure JG; Yong VW
    Neurosurgery; 1993 Sep; 33(3):495-501; discussion 501. PubMed ID: 8413883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT; Weiss MH; Law RE; Hinton DR
    J Neurosurg; 1995 Mar; 82(3):461-8. PubMed ID: 7861225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of tamoxifen as an antiproliferative agent in vitro for benign and malignant pediatric glial tumors.
    Pollack IF; Kawecki S
    Pediatr Neurosurg; 1995; 22(6):281-8. PubMed ID: 7577661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staurosporine differentially inhibits glioma versus non-glioma cell lines.
    Baltuch GH; Dooley NP; Couldwell WT; Yong VW
    J Neurooncol; 1993 May; 16(2):141-7. PubMed ID: 8289091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction for proliferation of glioma cells in vitro occurs predominantly through a protein kinase C-mediated pathway.
    Baltuch GH; Yong VW
    Brain Res; 1996 Feb; 710(1-2):143-9. PubMed ID: 8963653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.
    Pollack IF; Randall MS; Kristofik MP; Kelly RH; Selker RG; Vertosick FT
    Cancer Res; 1990 Nov; 50(22):7134-8. PubMed ID: 2224848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines.
    Couldwell WT; Hinton DR; He S; Chen TC; Sebat I; Weiss MH; Law RE
    FEBS Lett; 1994 May; 345(1):43-6. PubMed ID: 8194597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of calphostin C, a potent photodependent protein kinase C inhibitor, on the proliferation of glioma cells in vitro.
    Pollack IF; Kawecki S
    J Neurooncol; 1997 Feb; 31(3):255-66. PubMed ID: 9049854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.
    Chen TC; Su S; Fry D; Liebes L
    Cancer; 2003 May; 97(9 Suppl):2363-73. PubMed ID: 12712458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
    Courage C; Budworth J; Gescher A
    Br J Cancer; 1995 Apr; 71(4):697-704. PubMed ID: 7710931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor.
    Pollack IF; Kawecki S; Lazo JS
    J Neurosurg; 1996 Jun; 84(6):1024-32. PubMed ID: 8847567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C activity correlates with the growth rate of malignant gliomas: Part II. Effects of glioma mitogens and modulators of protein kinase C.
    Couldwell WT; Antel JP; Yong VW
    Neurosurgery; 1992 Oct; 31(4):717-24; discussion 724. PubMed ID: 1407458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor.
    Zhang W; Law RE; Hinton DR; Couldwell WT
    Cancer Lett; 1997 Nov; 120(1):31-8. PubMed ID: 9570383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen-induced growth arrest and apoptosis in pituitary tumor cells in vitro via a protein kinase C-independent pathway.
    Simard M; Zhang W; Hinton DR; Chen TC; Weiss MH; Su YZ; Gopalakrishna R; Law RE; Couldwell WT
    Cancer Lett; 2002 Nov; 185(2):131-8. PubMed ID: 12169386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of radiosensitivity by tamoxifen in C6 glioma cells.
    Zhang W; Yamada H; Sakai N; Niikawa S; Nozawa Y
    Neurosurgery; 1992 Oct; 31(4):725-9; discussion 729-30. PubMed ID: 1407459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines.
    Oude Weernink PA; Verheul E; Kerkhof E; van Veelen CW; Rijksen G
    Neurosurgery; 1996 Jan; 38(1):108-13; discussion 113-4. PubMed ID: 8747958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor.
    Ikemoto H; Tani E; Matsumoto T; Nakano A; Furuyama J
    J Neurosurg; 1995 Dec; 83(6):1008-16. PubMed ID: 7490614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.
    Couldwell WT; Uhm JH; Antel JP; Yong VW
    Neurosurgery; 1991 Dec; 29(6):880-6; discussion 886-7. PubMed ID: 1758601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of tamoxifen and tumor necrosis factor alpha on human glioblastoma cells.
    Iwasaki K; Toms SA; Barnett GH; Estes ML; Gupta MK; Barna BP
    Cancer Immunol Immunother; 1995 Apr; 40(4):228-34. PubMed ID: 7750120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen modulation of carboplatin cytotoxicity in a human U-138 glioma cell line.
    Mastronardi L; Farah JO; Puzzilli F; Ruggeri A
    Clin Neurol Neurosurg; 1998 Jun; 100(2):89-93. PubMed ID: 9746294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.